Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
Heron Therapeutics, Inc. (Nasdaq: HRTX) announced its participation in the 2022 Jefferies Global Healthcare Conference on June 8, 2022, at 8:30 am ET. The event runs from June 8-10 in New York, NY. A live webcast will be available on their website under the Investor Resources section. Heron focuses on developing therapeutic innovations to enhance medical care for patients, particularly in acute care and oncology.
- None.
- None.
SAN DIEGO, May 26, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced that company management will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference on Wednesday, June 8, 2022 at 8:30 am ET. The conference is taking place June 8-10th, 2022 in New York, NY.
A live webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447
View original content:https://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-the-2022-jefferies-global-healthcare-conference-301555685.html
SOURCE Heron Therapeutics, Inc.
FAQ
When will Heron Therapeutics participate in the Jefferies Global Healthcare Conference?
Where is the 2022 Jefferies Global Healthcare Conference being held?
How can I watch the Heron Therapeutics conference presentation?
What is the main focus of Heron Therapeutics?
What is the stock symbol for Heron Therapeutics?
